Dam, you guys are SO stubborn..
Bingo! Actavis knows Linzess is the "inferior" drug, yet they still have no interest in SGYP
Says a lot. ACT has been on a major buying spree. They have billions and billions of dollars, could spit out and chew a company like SGYP but have no interest in their product. They instead choose IRWD and their inferior compound. Says a lot about the truth behind plecanatide and SGYP.
What is going on??
The market says this is a DOG. SCMP rules this space..
That is all I can say..
So it seems to many here..
shares than Vanguard and Fidelity if we can believe your stories, LOL...
Seen it before.. Should have bailed at $4.68
Zero institutional support..